Jun 7 2010
DSM Biomedical, a global leader in biomedical materials science, and its Berkeley based operation, DSM PTG, today announced the Company will both exhibit and present at the upcoming Medical Design and Manufacturing East Conference & Exposition (MD&M East) held June 7 – 10, 2010 at the Jacob K. Javits Convention Center in New York City.
DSM's Dyneema Purity biomaterial
During his June 9th presentations, CEO and President of DSM PTG, Bob Ward, will lead a session discussing exciting applications under contract development by DSM that use biomaterials in a new role – the treatment and prevention of infectious diseases. He will also participate in an expert panel addressing his experience and the challenges of using new materials in medical devices.
“With extensive experience in both biomaterials and medical devices, DSM Biomedical is a leader in bringing new polymers and specialty chemicals to material-intensive medical applications.” said Bob Ward. “Our well-established, vertically integrated approach to device development, backed up by DSM’s extensive capabilities in specialty materials manufacturing and testing is unique in our industry. This depth and our program of continual improvement and technology development enable us to stay in the forefront of biomaterials technology.”
To learn more about DSM Biomedical’s product portfolio and technologies, please visit Booth #741 at MD&M East 2010